SILO — Silo Pharma Balance Sheet
0.000.00%
- $3.36m
- -$3.72m
- $0.07m
- 16
- 26
- 32
- 13
Annual balance sheet for Silo Pharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 1.13 | 10.3 | 11.4 | 7.67 | 7.08 |
Net Total Receivables | 0.024 | 0 | 0.066 | 0 | — |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 1.43 | 10.4 | 11.6 | 7.68 | 7.11 |
Net Intangible Assets | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 1.43 | 10.5 | 11.6 | 7.75 | 7.41 |
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.142 | 0.49 | 0.436 | 0.776 | 1.66 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.146 | 1.43 | 1.3 | 1.57 | 2.38 |
Redeemable Preferred Stock | |||||
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 1.28 | 9.06 | 10.3 | 6.18 | 5.03 |
Total Liabilities & Shareholders' Equity | 1.43 | 10.5 | 11.6 | 7.75 | 7.41 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |